CPSA

Chemical & Pharmaceutical Structure Analysis
Where Technology and Solutions Meet

CPSA 2009

Impacting Biology through Analysis

October 26-29, 2009
Langhore, PA

Final Program

Monday, October 26

8:30 pm - 4:30 pm

Short Courses
Bucks County Sheraton Hotel
2nd Floor Boardroom Lobby

Method Development for LC/MS: Traditional Approaches and Emerging Trends
Roger Hayes, Schering-Plough
Shane Needham, Alturas Analytics

High Throughput Drug Discovery Support: LC/MS Strategies for Method Development, Profiling and Workflow Solutions
Mark Hayward, Lundbeck Research USA
Ken Lewis, OpAns

Is Poor Bioavailability in Early drug Discovery a Problem and If So, How Can We Solve It?
Ayman El-Kattan, Pfizer

Analysis of Peptides and Proteins: Sample Preparation to Identification to Quantitation
Nalini Sadagopan, Agilent Technologies
Gary Valaskovic, New Objective
Chuck Witkowski, Protein Discovery

Small Molecule Structure Elucidation by NMR
David J. Russell, Varian

5:30 am - 7:30 pm

Reception & Reigistration

7:30 am - 10:00 pm

Sponsors Dinner Event

Tuesday, October 27

7:30 am - 8:30 am

Reigistration & Continental Breakfast

8:30 am - 8:35 am

Welcome
Mike S. Lee, Milestone Development Services

8:30am - 8:45 am

Objectives, Format & Opening Remarks
Kevin Bateman, Merck Frosst Canada

8:45 am - 9:30 am

Plenary Lecture

The Impact of High-Performance Mass Spectrometry on Biology Research
Ian Jardine, Thermo Fisher Scientific

9:30 am - 9:45 am

Break / Roundtables

9:45 am - 11:15 am

High Performance Workflows: Emerging Applications for Simultaneous Qualitative-Quantitative Analysis
Discussion Leader: Todd Gillespie, Eli Lilly and Company

An Automated Multi-Assay Sample Preparation Suite for Regulated Bioanalysis
Joseph A. Tweed, Pfizer

Characteristics of a Mass Spectrometer Designed to be Optimized for Both Quantitative and Qualitative Bioanalytical Analyses
Thomas R. Covey, MDS Analytical Technologies

An Integrated Approach to In Vitro and In Vivo Metabolite Quantitation Based on High Resolution Full Scan MS Data
Jonathan L. Josephs, Bristol-Myers Squibb

Hybrid Microfluidics for Sample Processing and Separations
Aaron Wheeler, University of Toronto

11:15 am - 11:30 am

Break / Roundtables

11:30 pm - 12:45 pm

Complimentary Lunch / Roundtables

Why Biomarkers for Toxicology and Clinical Diagnostics Fail... or Don't Have Broader Acceptance
Discussion Leader: Patrick Bennett, Tandem Labs

Use of Mass Spectrometry Based Bioanalytics for Liver Toxicity Biomarker Study
Mark Qian, Millennium Pharmaceuticals

Targeted Biomarker Profiling by LC/MS/MS
Bob Xiong, Tandem Labs

12:45 pm - 3:00 pm

Poster Session/Rountables
Session Chairs:
James L. Stephenson, RTI International
Matthew E. Szapacs, GlaxoSmithKline
Tracie Williams, Centers for Disease Control & Prevention
Donglu Zhang, Bristol-Myers Squibb
Download Poster Abstracts

2:00 pm - 3:00 pm

Rountable Workshop Sessions
Held in conjunction with the North Jersey ACS Chromatography and NMR Discussion Groups

High Performance Sample Preparation for the Quantitation of Proteins and Peptides
Bradley L. Ackermann, Eli Lilly and Company
Russell Grant, LabCorp
Chuck Witkowski, Protein Discovery

Discovery to Manufacturing: The Use of Simulated Moving Bed Chromatography ’Äì Orochem Technologies
Anil Oroskar, Orochem Technologies

Advances in Integrated Analysis: From Drug Metabolism to Biological Systems ’Äì Shimadzu
Terry Adams, Shimadzu
Scott Kuzdzal, Shimadzu

GMP NMR - North Jersey NMR Discussion Group
David Detlefsen, Novatia
István Pelczer, Princeton University
David Russell, Varian

3:00 pm - 4:15 pm

Small Molecule Biomarker Assay Development and Validation
Held in conjunction with the North Jersey ACS Chromatography and NMR Discussion Groups
Discussion Leaders: Petia Shipkova, Bristol-Myers Squibb
Naidong Weng, Johnson & Johnson

Quantitation of Endogenous Markers in Drug Discovery
Petia Shipkova, Bristol-Myers Squibb

Validation of Clinical Biomarkers
Richard Edom, R.W. Johnson PRI

Small Molecule Biomarkers: The Journey From Initial Discovery Through Clinical Utility Validation
Eric Milgram, Applied Scientific Consulting

4:15 pm - 4:45 pm

Break / Roundtables

4:45 pm - 6:00 pm

Small Interfering RNA and Gene Silencing: Emerging Opportunities for Analysis in Drug Discovery and the Potential of a Bioanalytical Equivalent
Held in conjunction with the North Jersey ACS Chromatography and NMR Discussion Groups
Discussion Leader: Roy Vaz, Sanofi-Aventis

Bioanalytical Methods and Issues with Antisense Oligonucleotides
John S. Grundy, ISIS Pharmaceuticals

Strategies and Methods for the LC/MS Analysis of siRNA
Mark Cancilla, Sirna Therapeutics

6:00 pm - 8:00 pm

Sponsor Hospitality - Evening Workshops
Held in conjunction with the North Jersey ACS Chromatography and NMR Discussion Groups

Microscale LC Advantages for Pharmaceutical Applications: Fast, Robust and Cost-Effective Results - Eksigent
Robert Turner, Comentis

Practical Aspects in Quantitating Oligonucleotides by LC/MS
- Gel Analytics
Paul Winkler, GEL Analytics
J. Shawn Roach, Dicerna Pharmaceuticals

Instrument Leasing and Asset Management - McKinley Scientific
Martin Steel, McKinley Scientific

Advanced Chemistry Development/ACD Labs Vendor Night
Gonzalo Hernandez, Lexicon Pharmaceuticals
Ryan Sasaki, ACD Labs

Wednesday, October 28

7:30 am - 8:30 am

Reigistration & Continental Breakfast

8:30 am - 10:00 am

Protein Based Biomarkers
Discussion Leader: Nathan A. Yates, Merck Research Laboratories

Differential Mass Spectrometry - A Promising Approach for Biomarker Discovery, Validation, and Qualification
Ron Hendrickson, Merck Research Laboratories

Practical Considerations in MRM-Based Assay Development for Peptide Quantitation in Plasma
Susan Abbatiello, The Broad Institute of MIT and Harvard

Urinary Biomarkers of Kidney Injury: Evaluation, and Regulatory Approval Process
Dave Gerhold, Merck Research Laboratories

10:00 am - 10:30 am

Break / Roundtables

10:30 am - 12:15 pm

Tools for Understanding Biology Through Analysis
Discussion Leader: Walter A. Korfmacher, Schering-Plough Research Institute

Maximizing Utility of PK/PD Studies during Lead Optimization
Richard Morrison, Schering-Plough Research Institute

Using MALDI Imaging Mass Spectrometry for Biomarker Discovery
Michelle Reyzer, Vanderbilt University

Hurel Static and Flow-Based Systems: Tools for Drug Metabolism and Toxicology
Martin Yarmush, Rutgers University

12:15 pm - 2:15 pm

Exhibition Open

1:15 pm - 2:15 pm

Roundtable Workshop Sessions / Sponsored Lunch

Biomarker Identification, Qualification, Validation and Applications - Eurofins Medinet
Jamie Bendrick-Peart, Eurofins Medinet

High Performance Nanospray - New Objective
Susan Abbatiello, The Broad Institute of MIT and Harvard
Thomas R. Covey, MDS Analytical Technologies
Rick King, PharmaCadence
Gary Valaskovic, New Objective

Accelerator Mass Spectrometry: High Performance Clinical Development with Microdoses and Microtracers - Vitalea Science
Thomas A. Baillie, University of Washington
Steve Unger, Wyeth Research
John Vogel, Vitalea Science

2:15 pm - 3:30 pm

Toxicity Markers
Held in conjunction with the North Jersey ACS Drug Metabolism and Mass Spectrometry Discussion Groups and the Delaware Valley Drug Metabolism Discussion Group
Discussion Leader: William H. Schaefer, Merck Research Laboratories

Metabonomics and Model Characterization as a Foundation for Biomarker Discovery
Donald G. Robertson, Bristol-Myers Squibb

Development and Application of Toxicity Biomarkers
William H. Schaefer, Merck Research Laboratories

3:30 pm - 5:30 pm

Poster Session / Vendor Session
Held in conjunction with the North Jersey ACS Drug Metabolism and Mass Spectrometry Discussion Groups and the Delaware Valley Drug Metabolism Discussion Group
Discussion Leaders:
Mark J. Hayward, Lundbeck USAResearch
Ragu Ramanathan, Bristol-Myers Squibb

Download Poster Abstracts | Download Vender Session Abstracts

6:30 pm - 7:30 pm

Dinner
Held in conjunction with the North Jersey ACS Drug Metabolism and Mass Spectrometry Discussion Groups and the Delaware Valley Drug Metabolism Discussion Group

7:30 pm - 7:45 pm

Announcements

CPSA Shanghai 2010 Introduction
Yining Zhao, Pfizer

CPSA - Distinguished Analytical Scientist Award Presentation
2009 Recipient: Walter A. Korfmacher, Schering-Plough Research Institute
Presented by:Bradley L. Ackermann, Eli Lilly and Company

Using Mass Spectrometry in New Drug Discovery: Past, Present and Future
Walter A. Korfmacher, Schering-Plough Research Institute

The Impact of Mass Spectrometry in Pharmaceutical Lead Optimization - Studies on Metabolic Activation
Thomas A. Baillie, University of Washington

Thursday, October 29

7:30 am - 8:30 am

Reigistration & Continental Breakfast

8:30 am - 10:00 am

Peptide and Protein Quantitation: Are Trypsin and MRM Sufficient?
Discussion Leader: Yves LeBlanc, MDS Sciex

Mass Spectrometric Protein Quantification - The Good, Bad and Ugly
Alfred Yergey, National Institutes of Health

Strategies to Improve SRM Selectivity and Alternative Approaches for Proteins and Peptides Quantitation
Gérard Hopfgartner, University of Geneva

10:00 am - 10:30 am

Break / Roundtables

10:30 am - 12:15 pm

High Throughput Quantitation: Going Faster by Going Faster and Going Slower
Discussion Leader: Christopher A. Evans, GlaxoSmithKline

Ultra-Fast Chromatography Using Fused-Core Columns To Increase Bioanalytical Throughput
Ethan Badman, Hoffmann-La Roche, Inc.

Parallel Offline Sample Prep using Electrophoretic Fractionation and Enrichment
Chuck Witkowski, Protein Discovery

Laser Diode Thermal Desorption (LDTD) an Alternative to the LC for High-Throughput Quantitation: Some Early Case Studies
Donald Gray, Bioanalytical Systems, Inc.

12:15 pm - 2:00 pm

Complimentary Lunch / Roundtables

Maintaining our Innovative Fitness during Times of Transition
Discussion Leader: Lucinda H. Cohen, Merck Research Laboratories

Distributed R&D: Isn't There Something Better than Spreadsheets and eMail?
Randy Julian, Indigo BioSystems

Fostering Automation Implementation through Global Collaboration
Lucinda H. Cohen, Merck Research Laboratories

Wrap Up & Adjourn
Kevin P. Bateman, Merck Frosst Canada

©2010 Milestone Development Services. All rights reserved.